EUVIMEDEUVIMED entdecken
Crossref

Engineered Prussian Blue‐Curcumin Nanozyme with RONS Scavenging Properties for Augmented Reversible Treatment of Cardiac Hypertrophy

Anlin Luo, Jing Tan, Haisong Wang, Manman Yang, Shuojing Wang, Chengzeng Wang, Yachao Wang, Lin Liu iD

Advanced Healthcare Materials · 2025-06 · 14 (15)

DOI: 10.1002/adhm.202404201 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 24.04.2025. Verfasst von Anlin Luo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ultrasound, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, P. R. China. Hauptthemen laut MEDLINE: Ferrocyanides, Curcumin, Cardiomegaly, Reactive Oxygen Species. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Henan, Henan Medical Science and Technique Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pathological cardiac hypertrophy, often triggered by the excessive production and accumulation of reactive oxygen and nitrogen species (RONS), may ultimately lead to heart failure. The treatment of myocardial hypertrophy often involves antioxidant stress therapy. In this study, by coordinating curcumin with ferric ions during the synthesis of Prussian blue nanoparticles, a Prussian blue‐curcumin (PB‐Cur) nanozyme is successfully engineered with exceptional reactive oxygen and nitrogen species (RONS) elimination capabilities. Following PVP modification, the PB‐Cur nanozyme exhibited favorable biocompatibility and stability in aqueous solutions. Furthermore, the PB‐Cur nanozyme shows remarkable reversible treatment efficacy against myocardial hypertrophy in both in vitro and in vivo models. After one week of treatment, the PB‐Cur group in the transverse aortic constriction (TAC)‐induced cardiac hypertrophy models displayed a notable decrease in myocardial hypertrophy and fibrosis. Echocardiographic findings also revealed a substantial improvement in cardiac function among TAC mice following PB‐Cur administration. Mechanistically, through reactive oxygen species (ROS) elimination, the PB‐Cur effectively downregulated oxidative stress‐related pathways, including MAPK and PI3K‐Akt, which hold promise for treating oxidative stress‐related cardiac diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerrocyanidesCurcuminCardiomegalyReactive Oxygen SpeciesNanoparticlesAnimalsMiceOxidative StressMaleMice, Inbred C57BL

Stichwörter der Autor:innen

PB‐Cur nanozymeRONS scavengingcardiac hypertrophyoxidative stress

Substanzen

ferric ferrocyanideFerrocyanidesCurcuminReactive Oxygen Species

Autor:innen und Institutionen

  • Department of Ultrasound, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, P. R. China.
  • Henan Institute of Interconnected Intelligent Health Management, Henan Key Laboratory of Chronic Disease Prevention and Therapy & Intelligent Health Management, Zhengzhou, Henan, 450052, China.
  • Reproductive Medical Center, Henan Key Laboratory of Reproduction and Genetics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, China.

ORCID-Profile: Lin Liu

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Henan
  • Henan Medical Science and Technique Foundation

Zitieren

APA

Luo, A., Tan, J., Wang, H., Yang, M., Wang, S., Wang, C., Wang, Y., & Liu, L. (2025). Engineered Prussian Blue‐Curcumin Nanozyme with RONS Scavenging Properties for Augmented Reversible Treatment of Cardiac Hypertrophy. Advanced Healthcare Materials, 14(15). https://doi.org/10.1002/adhm.202404201

Vancouver

Luo A, Tan J, Wang H, Yang M, Wang S, Wang C, et al. Engineered Prussian Blue‐Curcumin Nanozyme with RONS Scavenging Properties for Augmented Reversible Treatment of Cardiac Hypertrophy. Advanced Healthcare Materials. 2025;14(15). doi:10.1002/adhm.202404201

BibTeX
@article{Luo2025,
  author = {Luo, Anlin and Tan, Jing and Wang, Haisong and Yang, Manman and Wang, Shuojing and Wang, Chengzeng and Wang, Yachao and Liu, Lin},
  title = {Engineered Prussian Blue‐Curcumin Nanozyme with RONS Scavenging Properties for Augmented Reversible Treatment of Cardiac Hypertrophy},
  journal = {Advanced Healthcare Materials},
  year = {2025},
  volume = {14},
  number = {15},
  doi = {10.1002/adhm.202404201}
}
Kostenlos starten →